Barclays »

Outlook Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $66k 5.5k 12.01

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
Sphera Funds Management
BlackRock
Velan Capital Investment Management
Caligan Partners
Vanguard Group
Schonfeld Strategic Advisors
Geode Capital Management
Northern Trust
Bank of America Corporation
Walleye Trading Advisors
Hrt Financial
Millennium Management

View all funds holding Outlook Therapeutics